Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

NCT00646321 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: budesonide/formoterol (Symbicort)
DRUG: budesonide

Sponsor

AstraZeneca